Global X FTSE Southeast Asia ETF vs InMode Ltd — how do they compare? Global X FTSE Southeast Asia ETF trades at $21.43, while InMode Ltd trades at $15.25 (market cap $872.08M). The key difference: Global X FTSE Southeast Asia ETF is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals.
| ASEA | INMD | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $21.53 | $16.62 |
52-Week Low | $16.86 | $12.76 |
Market Cap | — | $872.08M |
Enterprise Value | — | $375.42M |
Signals from Pluang's Aura AI — not financial advice
ASEA stock trades at $21.43, showing minimal daily movement with a 0.14% gain. Technical indicators signal strong bullish momentum with moving averages unanimously positive and ADX readings above 50 indicating a strong trend. The stock faces immediate resistance at $22 with support clustered around $21. A dividend of $0.41 per share is scheduled for July 2026, providing long-term income potential for investors.
The bullish technical setup suggests potential for near-term upside toward resistance levels, though fundamental analysis is limited without current financial metrics. Investors should monitor upcoming earnings reports for revenue growth and profitability trends. Key risks include market volatility and the company's ability to maintain competitive positioning in its sector.
INMD trades at $15.23, up 0.26% today, with a neutral technical outlook and mixed earnings history including a Q1 2026 miss. The company reported Q2 2026 revenue of $95.6 million, consistent year-over-year, and maintains a strong gross profit margin of 76.52%. Recent news highlights an unsolicited acquisition offer from Steel Partners at $16.75 per share and shareholder activism urging rejection, creating uncertainty around corporate governance.
The stock presents a value opportunity with low P/E and EV/EBITDA ratios, but risks include earnings volatility, potential acquisition fallout, and ongoing securities fraud investigations. Analyst consensus is divided between Buy and Hold ratings, reflecting cautious optimism amid near-term headwinds. Long-term growth depends on execution of international expansion and innovation in medical technologies.
Trailing returns across standard periods
ASEA tracks the performance of the largest companies in Southeast Asia. It provides exposure to key emerging markets including Singapore, Indonesia, Thailand, and Malaysia, with a heavy focus on financials like DBS Group and Bank Central Asia.
Read more on ASEA →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →